Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs
- PMID: 21987773
- DOI: 10.1093/infdis/jir321
Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs
Abstract
Synthesis of the structural, surface glycoprotein (GP) of Ebola virus (EBOV) is dependent on transcriptional RNA editing phenomenon. Editing results in the insertion of an extra adenosine by viral polymerase at the editing site (7 consecutive template uridines) during transcription of GP gene of the wild-type virus (EBOV/7U). In this study, we demonstrate that passage of EBOV/7U in Vero E6 cells results in the appearance and rapid accumulation of a variant (EBOV/8U) containing an additional uridine at the editing site in the viral genome. EBOV/8U outgrows and eventually replaces the wild-type EBOV during 4-5 passages. On the contrary, infection of guinea pigs with EBOV/8U leads to the appearance and rapid predominance by EBOV/7U. These rapid conversions suggest that editing of the genomic RNA occurs at a higher frequency than previously thought. In addition, it indicates that the EBOV/7U phenotype has a selective advantage that is linked to controlled expression of GP and/or expression of secreted sGP, the primary gene product for wild-type EBOV. This study demonstrates the potential for insertion and deletion of uridines in the editing site of the EBOV genomic RNA, depending on environmental constraints.
Similar articles
-
RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor.J Infect Dis. 2015 Oct 1;212 Suppl 2:S226-33. doi: 10.1093/infdis/jiv309. Epub 2015 Jul 2. J Infect Dis. 2015. PMID: 26138826
-
Molecular characterization of guinea pig-adapted variants of Ebola virus.Virology. 2000 Nov 10;277(1):147-55. doi: 10.1006/viro.2000.0572. Virology. 2000. PMID: 11062045
-
VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.J Infect Dis. 2011 Nov;204 Suppl 3:S1011-20. doi: 10.1093/infdis/jir338. J Infect Dis. 2011. PMID: 21987737
-
Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.Expert Rev Mol Med. 2004 Sep 21;6(20):1-24. doi: 10.1017/S1462399404008300. Expert Rev Mol Med. 2004. PMID: 15383160 Review.
-
Review of Ebola virus infections in domestic animals.Dev Biol (Basel). 2013;135:211-8. doi: 10.1159/000178495. Epub 2013 May 14. Dev Biol (Basel). 2013. PMID: 23689899 Review.
Cited by
-
Integrated sequence and immunology filovirus database at Los Alamos.Database (Oxford). 2016 Apr 21;2016:baw047. doi: 10.1093/database/baw047. Print 2016. Database (Oxford). 2016. PMID: 27103629 Free PMC article.
-
Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.J Virol. 2011 Sep;85(17):8502-13. doi: 10.1128/JVI.02600-10. Epub 2011 Jun 22. J Virol. 2011. PMID: 21697477 Free PMC article.
-
A paramyxovirus-like model for Ebola virus bipartite promoters.PLoS Pathog. 2020 Nov 5;16(11):e1008972. doi: 10.1371/journal.ppat.1008972. eCollection 2020 Nov. PLoS Pathog. 2020. PMID: 33152032 Free PMC article.
-
New Perspectives on Ebola Virus Evolution.PLoS One. 2016 Aug 1;11(8):e0160410. doi: 10.1371/journal.pone.0160410. eCollection 2016. PLoS One. 2016. PMID: 27479005 Free PMC article.
-
Development of a New Reverse Genetics System for Ebola Virus.mSphere. 2021 May 5;6(3):e00235-21. doi: 10.1128/mSphere.00235-21. mSphere. 2021. PMID: 33952663 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical